{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T10:33:49Z","timestamp":1790332429808,"version":"4.1.0"},"reference-count":93,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,13]]},"DOI":"10.7759\/cureus.99148","type":"journal-article","created":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T22:20:07Z","timestamp":1765664407000},"source":"Crossref","is-referenced-by-count":3,"title":["The Fat-Pancreas Axis: A Narrative Review Unraveling the Role of Obesity in Pancreatic Diseases"],"prefix":"10.7759","author":[{"given":"George S","family":"Zacharia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"FNU","family":"Veena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huzefa","family":"Habib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allah","family":"Dad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Asare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Obesity: preventing and managing the global epidemic. Report of a WHO consultation","volume":"894","author":"World Health Organization","year":"2000","unstructured":"World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser. 2000, 894:i-xii.","journal-title":"World Health Organ Tech Rep Ser"},{"key":"ref2","unstructured":"World Obesity Atlas 2023. (2023). Accessed. December 6, 2025: https:\/\/www.worldobesity.org\/resources\/resource-library\/world-obesity-atlas-2023."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyz273","article-title":"Has the prevalence of overweight, obesity and central obesity levelled off in the United States? Trends, patterns, disparities, and future projections for the obesity epidemic","volume":"49","author":"Wang Y","year":"2020","unstructured":"Wang Y, Beydoun MA, Min J, Xue H, Kaminsky LA, Cheskin LJ. Has the prevalence of overweight, obesity and central obesity levelled off in the United States? Trends, patterns, disparities, and future projections for the obesity epidemic. Int J Epidemiol. 2020, 49:810-23. 10.1093\/ije\/dyz273","journal-title":"Int J Epidemiol"},{"key":"ref4","article-title":"Health impacts of obesity","volume":"31","author":"Djalalinia S","year":"2015","unstructured":"Djalalinia S, Qorbani M, Peykari N, Kelishadi R. Health impacts of obesity. Pak J Med Sci. 2015, 31:239-42.","journal-title":"Pak J Med Sci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.34","article-title":"Obesity","volume":"3","author":"Gonz\u00e1lez-Muniesa P","year":"2017","unstructured":"Gonz\u00e1lez-Muniesa P, M\u00e1rtinez-Gonz\u00e1lez MA, Hu FB, et al.. Obesity. Nat Rev Dis Primers. 2017, 3:17034. 10.1038\/nrdp.2017.34","journal-title":"Nat Rev Dis Primers"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/2252516","article-title":"Obesity, adipose tissue, and inflammation answered in questions","volume":"2022","author":"Guerreiro VA","year":"2022","unstructured":"Guerreiro VA, Carvalho D, Freitas P. Obesity, adipose tissue, and inflammation answered in questions. J Obes. 2022, 2022:2252516. 10.1155\/2022\/2252516","journal-title":"J Obes"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics12071681","article-title":"Link between insulin resistance and obesity\u2014from diagnosis to treatment","volume":"12","author":"Go\u0142acki J","year":"2022","unstructured":"Go\u0142acki J, Matuszek M, Matyjaszek-Matuszek B. Link between insulin resistance and obesity\u2014from diagnosis to treatment. Diagnostics (Basel). 2022, 12:1681. 10.3390\/diagnostics12071681","journal-title":"Diagnostics (Basel)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v9.i23.6624","article-title":"Nonalcoholic fatty pancreas disease: an emerging clinical challenge","volume":"9","author":"Zhang CL","year":"2021","unstructured":"Zhang CL, Wang JJ, Li JN, Yang Y. Nonalcoholic fatty pancreas disease: an emerging clinical challenge. World J Clin Cases. 2021, 9:6624-38. 10.12998\/wjcc.v9.i23.6624","journal-title":"World J Clin Cases"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/path.1700370314","article-title":"The islands of Langerhans in 19 cases of obesity","volume":"37","author":"Ogilvie RF","year":"1933","unstructured":"Ogilvie RF. The islands of Langerhans in 19 cases of obesity. J Pathol Bacteriol. 1933, 37:473-81. 10.1002\/path.1700370314","journal-title":"J Pathol Bacteriol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2011.4","article-title":"The clinical significance of pancreatic steatosis","volume":"8","author":"Smits MM","year":"2011","unstructured":"Smits MM, van Geenen EJ. The clinical significance of pancreatic steatosis. Nat Rev Gastroenterol Hepatol. 2011, 8:169-77. 10.1038\/nrgastro.2011.4","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000011293","article-title":"Prevalence and factors associated with nonalcoholic fatty pancreas disease and its severity in China","volume":"97","author":"Weng S","year":"2018","unstructured":"Weng S, Zhou J, Chen X, Sun Y, Mao Z, Chai K. Prevalence and factors associated with nonalcoholic fatty pancreas disease and its severity in China. Medicine (Baltimore). 2018, 97:e11293. 10.1097\/MD.0000000000011293","journal-title":"Medicine (Baltimore)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2016.12.012","article-title":"Ectopic fat accumulation in the pancreas and its clinical relevance: a systematic review, meta-analysis, and meta-regression","volume":"69","author":"Singh RG","year":"2017","unstructured":"Singh RG, Yoon HD, Wu LM, Lu J, Plank LD, Petrov MS. Ectopic fat accumulation in the pancreas and its clinical relevance: a systematic review, meta-analysis, and meta-regression. Metabolism. 2017, 69:1-13. 10.1016\/j.metabol.2016.12.012","journal-title":"Metabolism"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S508567","article-title":"Correlation between fatty pancreas disease and pancreatic diseases, perioperative complications of pancreatic surgery","volume":"17","author":"Wu Z","year":"2025","unstructured":"Wu Z, Li J. Correlation between fatty pancreas disease and pancreatic diseases, perioperative complications of pancreatic surgery. Cancer Manag Res. 2025, 17:723-30. 10.2147\/CMAR.S508567","journal-title":"Cancer Manag Res"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v5.i4.415","article-title":"Pancreatic steatosis: is it related to either obesity or diabetes mellitus?","volume":"5","author":"Pezzilli R","year":"2014","unstructured":"Pezzilli R, Calculli L. Pancreatic steatosis: is it related to either obesity or diabetes mellitus?. World J Diabetes. 2014, 5:415-9. 10.4239\/wjd.v5.i4.415","journal-title":"World J Diabetes"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.13122883","article-title":"Quantitative assessment of pancreatic fat by using unenhanced CT: pathologic correlation and clinical implications","volume":"271","author":"Kim SY","year":"2014","unstructured":"Kim SY, Kim H, Cho JY, et al.. Quantitative assessment of pancreatic fat by using unenhanced CT: pathologic correlation and clinical implications. Radiology. 2014, 271:104-12. 10.1148\/radiol.13122883","journal-title":"Radiology"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.4103\/sjmms.sjmms_526_23","article-title":"Extended review and updates of nonalcoholic fatty pancreas disease","volume":"12","author":"Habas E","year":"2024","unstructured":"Habas E, Farfar K, Habas E, Rayani A, Elzouki AN. Extended review and updates of nonalcoholic fatty pancreas disease. Saudi J Med Med Sci. 2024, 12:284-91. 10.4103\/sjmms.sjmms_526_23","journal-title":"Saudi J Med Med Sci"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e37580","article-title":"Non-invasive diagnosis of pancreatic steatosis with ultrasound images using deep learning network","volume":"10","author":"Sun Y","year":"2024","unstructured":"Sun Y, Zhang L, Huang JQ, Su J, Cui LG. Non-invasive diagnosis of pancreatic steatosis with ultrasound images using deep learning network. Heliyon. 2024, 10:e37580. 10.1016\/j.heliyon.2024.e37580","journal-title":"Heliyon"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.gie.2011.01.015","article-title":"A prospective evaluation of fatty pancreas by using EUS","volume":"73","author":"Sepe PS","year":"2011","unstructured":"Sepe PS, Ohri A, Sanaka S, et al.. A prospective evaluation of fatty pancreas by using EUS. Gastrointest Endosc. 2011, 73:987-93. 10.1016\/j.gie.2011.01.015","journal-title":"Gastrointest Endosc"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.gie.2024.04.2035","article-title":"Novel endoscopic ultrasound criteria for pancreatic steatosis: prospective study with histology as the gold standard","volume":"99","author":"Tanawat G","year":"2024","unstructured":"Tanawat G, Pausawasdi N, Angkathunyakul N, et al.. Novel endoscopic ultrasound criteria for pancreatic steatosis: prospective study with histology as the gold standard. Gastrointest Endosc. 2024, 99:AB859. 10.1016\/j.gie.2024.04.2035","journal-title":"Gastrointest Endosc"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.diii.2023.03.004","article-title":"Quantitative imaging predicts pancreatic fatty infiltration on routine CT examination","volume":"104","author":"Previtali C","year":"2023","unstructured":"Previtali C, Sartoris R, Rebours V, et al.. Quantitative imaging predicts pancreatic fatty infiltration on routine CT examination. Diagn Interv Imaging. 2023, 104:359-67. 10.1016\/j.diii.2023.03.004","journal-title":"Diagn Interv Imaging"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-017-5914-3","article-title":"CT density in the pancreas is a promising imaging predictor for pancreatic ductal adenocarcinoma","volume":"24","author":"Fukuda Y","year":"2017","unstructured":"Fukuda Y, Yamada D, Eguchi H, et al.. CT density in the pancreas is a promising imaging predictor for pancreatic ductal adenocarcinoma. Ann Surg Oncol. 2017, 24:2762-9. 10.1245\/s10434-017-5914-3","journal-title":"Ann Surg Oncol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1097\/MPA.0000000000002288","article-title":"Magnetic resonance imaging-based assessment of pancreatic fat strongly correlates with histology-based assessment of pancreas composition","volume":"53","author":"Kiemen AL","year":"2024","unstructured":"Kiemen AL, Dbouk M, Diwan EA, et al.. Magnetic resonance imaging-based assessment of pancreatic fat strongly correlates with histology-based assessment of pancreas composition. Pancreas. 2024, 53:e180-6. 10.1097\/MPA.0000000000002288","journal-title":"Pancreas"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1007\/s10334-013-0421-4","article-title":"Initial clinical application of modified Dixon with flexible echo times: hepatic and pancreatic fat assessments in comparison with 1H MRS","volume":"27","author":"Livingstone RS","year":"2014","unstructured":"Livingstone RS, Begovatz P, Kahl S, et al.. Initial clinical application of modified Dixon with flexible echo times: hepatic and pancreatic fat assessments in comparison with 1H MRS. MAGMA. 2014, 27:397-405. 10.1007\/s10334-013-0421-4","journal-title":"MAGMA"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2014.1","article-title":"Fatty pancreas, insulin resistance, and \u03b2-cell function: a population study using fat-water magnetic resonance imaging","volume":"109","author":"Wong VW","year":"2014","unstructured":"Wong VW, Wong GL, Yeung DK, et al.. Fatty pancreas, insulin resistance, and \u03b2-cell function: a population study using fat-water magnetic resonance imaging. Am J Gastroenterol. 2014, 109:589-97. 10.1038\/ajg.2014.1","journal-title":"Am J Gastroenterol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1097\/RLI.0000000000000496","article-title":"Preoperative evaluation of pancreatic fibrosis and lipomatosis: correlation of magnetic resonance findings with histology using magnetization transfer imaging and multigradient echo magnetic resonance imaging","volume":"53","author":"Schawkat K","year":"2018","unstructured":"Schawkat K, Eshmuminov D, Lenggenhager D, et al.. Preoperative evaluation of pancreatic fibrosis and lipomatosis: correlation of magnetic resonance findings with histology using magnetization transfer imaging and multigradient echo magnetic resonance imaging. Invest Radiol. 2018, 53:720-7. 10.1097\/RLI.0000000000000496","journal-title":"Invest Radiol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101842","article-title":"Evidence for a causal link between intra-pancreatic fat deposition and pancreatic cancer: a prospective cohort and Mendelian randomization study","volume":"5","author":"Yamazaki H","year":"2024","unstructured":"Yamazaki H, Streicher SA, Wu L, et al.. Evidence for a causal link between intra-pancreatic fat deposition and pancreatic cancer: a prospective cohort and Mendelian randomization study. Cell Rep Med. 2024, 5:101842. 10.1016\/j.xcrm.2024.101842","journal-title":"Cell Rep Med"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.4158\/EP.7.1.44","article-title":"Free fatty acids-the link between obesity and insulin resistance","volume":"7","author":"Boden G","year":"2001","unstructured":"Boden G. Free fatty acids-the link between obesity and insulin resistance. Endocr Pract. 2001, 7:44-51. 10.4158\/EP.7.1.44","journal-title":"Endocr Pract"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-018-4627-x","article-title":"Exercise training decreases pancreatic fat content and improves beta cell function regardless of baseline glucose tolerance: a randomised controlled trial","volume":"61","author":"Heiskanen MA","year":"2018","unstructured":"Heiskanen MA, Motiani KK, Mari A, et al.. Exercise training decreases pancreatic fat content and improves beta cell function regardless of baseline glucose tolerance: a randomised controlled trial. Diabetologia. 2018, 61:1817-28. 10.1007\/s00125-018-4627-x","journal-title":"Diabetologia"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.5152\/tjg.2018.17696","article-title":"Can pancreatic steatosis affect exocrine functions of pancreas?","volume":"29","author":"Tahtac\u0131 M","year":"2018","unstructured":"Tahtac\u0131 M, Alg\u0131n O, Karakan T, et al.. Can pancreatic steatosis affect exocrine functions of pancreas?. Turk J Gastroenterol. 2018, 29:588-94. 10.5152\/tjg.2018.17696","journal-title":"Turk J Gastroenterol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.3390\/nu11040912","article-title":"Changes in pancreatic fat content following diet-induced weight loss","volume":"11","author":"Jiang Y","year":"2019","unstructured":"Jiang Y, Spurny M, Sch\u00fcbel R, et al.. Changes in pancreatic fat content following diet-induced weight loss. Nutrients. 2019, 11:912. 10.3390\/nu11040912","journal-title":"Nutrients"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.3516","article-title":"Aerobic training reduces pancreatic fat content and improves \u03b2-cell function: a randomized controlled trial using IDEAL-IQ magnetic resonance imaging","volume":"38","author":"Li M","year":"2022","unstructured":"Li M, Zheng Q, Miller JD, et al.. Aerobic training reduces pancreatic fat content and improves \u03b2-cell function: a randomized controlled trial using IDEAL-IQ magnetic resonance imaging. Diabetes Metab Res Rev. 2022, 38:e3516. 10.1002\/dmrr.3516","journal-title":"Diabetes Metab Res Rev"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.2478\/rjim-2019-0005","article-title":"Non-alcoholic fatty pancreas disease - practices for clinicians","volume":"57","author":"Pinte L","year":"2019","unstructured":"Pinte L, Balaban DV, B\u0103icu\u015f C, Jinga M. Non-alcoholic fatty pancreas disease - practices for clinicians. Rom J Intern Med. 2019, 57:209-19. 10.2478\/rjim-2019-0005","journal-title":"Rom J Intern Med"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.2001.280.5.R1332","article-title":"Troglitazone stimulates pancreatic growth in congenitally CCK-A receptor-deficient OLETF rats","volume":"280","author":"Jia DM","year":"2001","unstructured":"Jia DM, Fukumitsu KI, Tabaru A, Akiyama T, Otsuki M. Troglitazone stimulates pancreatic growth in congenitally CCK-A receptor-deficient OLETF rats. Am J Physiol Regul Integr Comp Physiol. 2001, 280:R1332-40. 10.1152\/ajpregu.2001.280.5.R1332","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnesp.2023.12.005","article-title":"Effects of liraglutide on intrapancreatic fat deposition in patients with type 2 diabetes","volume":"59","author":"Kuriyama T","year":"2024","unstructured":"Kuriyama T, Ishibashi C, Kozawa J, et al.. Effects of liraglutide on intrapancreatic fat deposition in patients with type 2 diabetes. Clin Nutr ESPEN. 2024, 59:208-13. 10.1016\/j.clnesp.2023.12.005","journal-title":"Clin Nutr ESPEN"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1097\/MPA.0b013e3182153922","article-title":"Pancreatic ultrastructural enhancement due to telmisartan plus sitagliptin treatment in diet-induced obese C57BL\/6 mice","volume":"40","author":"Souza-Mello V","year":"2011","unstructured":"Souza-Mello V, Greg\u00f3rio BM, Relvas-Lucas B, da Silva Faria T, Aguila MB, Mandarim-de-Lacerda CA. Pancreatic ultrastructural enhancement due to telmisartan plus sitagliptin treatment in diet-induced obese C57BL\/6 mice. Pancreas. 2011, 40:715-22. 10.1097\/MPA.0b013e3182153922","journal-title":"Pancreas"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1007\/s11655-014-1986-0","article-title":"Effects of berberine and cinnamic acid on palmitic acid-induced intracellular triglyceride accumulation in NIT-1 pancreatic \u03b2 cells","volume":"22","author":"Zhao L","year":"2016","unstructured":"Zhao L, Jiang SJ, Lu FE, Xu LJ, Zou X, Wang KF, Dong H. Effects of berberine and cinnamic acid on palmitic acid-induced intracellular triglyceride accumulation in NIT-1 pancreatic \u03b2 cells. Chin J Integr Med. 2016, 22:496-502. 10.1007\/s11655-014-1986-0","journal-title":"Chin J Integr Med"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-4236","article-title":"The effects of bariatric surgery on pancreatic lipid metabolism and blood flow","volume":"100","author":"Honka H","year":"2015","unstructured":"Honka H, Koffert J, Hannukainen JC, et al.. The effects of bariatric surgery on pancreatic lipid metabolism and blood flow. J Clin Endocrinol Metab. 2015, 100:2015-23. 10.1210\/jc.2014-4236","journal-title":"J Clin Endocrinol Metab"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2012-302779","article-title":"Classification of acute pancreatitis--2012: revision of the Atlanta classification and definitions by international consensus","volume":"62","author":"Banks PA","year":"2013","unstructured":"Banks PA, Bollen TL, Dervenis C, et al.. Classification of acute pancreatitis--2012: revision of the Atlanta classification and definitions by international consensus. Gut. 2013, 62:102-11. 10.1136\/gutjnl-2012-302779","journal-title":"Gut"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1007\/s11695-025-07778-9","article-title":"The effects of metabolic bariatric surgery on intra-pancreatic fat deposition and total pancreas volume: a systematic review and meta-analysis","volume":"35","author":"Wang Y","year":"2025","unstructured":"Wang Y, Liu Y, Petrov MS. The effects of metabolic bariatric surgery on intra-pancreatic fat deposition and total pancreas volume: a systematic review and meta-analysis. Obes Surg. 2025, 35:1513-24. 10.1007\/s11695-025-07778-9","journal-title":"Obes Surg"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1016\/j.pan.2014.10.007","article-title":"The clinical relevance of obesity in acute pancreatitis: targeted systematic reviews","volume":"15","author":"Premkumar R","year":"2015","unstructured":"Premkumar R, Phillips AR, Petrov MS, Windsor JA. The clinical relevance of obesity in acute pancreatitis: targeted systematic reviews. Pancreatology. 2015, 15:25-33. 10.1016\/j.pan.2014.10.007","journal-title":"Pancreatology"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1016\/j.suc.2008.07.009","article-title":"Lithogenesis and bile metabolism","volume":"88","author":"Lambou-Gianoukos S","year":"2008","unstructured":"Lambou-Gianoukos S, Heller SJ. Lithogenesis and bile metabolism. Surg Clin North Am. 2008, 88:1175-94. 10.1016\/j.suc.2008.07.009","journal-title":"Surg Clin North Am"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.111.233049","article-title":"The complex metabolic mechanisms relating obesity to hypertriglyceridemia","volume":"31","author":"Eckel RH","year":"2011","unstructured":"Eckel RH. The complex metabolic mechanisms relating obesity to hypertriglyceridemia. Arterioscler Thromb Vasc Biol. 2011, 31:1946-8. 10.1161\/ATVBAHA.111.233049","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabet.2016.09.005","article-title":"Efficacy and safety of DPP-4 inhibitors in patients with type 2 diabetes: meta-analysis of placebo-controlled randomized clinical trials","volume":"43","author":"Rehman MB","year":"2017","unstructured":"Rehman MB, Tudrej BV, Soustre J, et al.. Efficacy and safety of DPP-4 inhibitors in patients with type 2 diabetes: meta-analysis of placebo-controlled randomized clinical trials. Diabetes Metab. 2017, 43:48-58. 10.1016\/j.diabet.2016.09.005","journal-title":"Diabetes Metab"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2013.2720","article-title":"Glucagonlike peptide 1-based therapies and risk of hospitalization for acute pancreatitis in type 2 diabetes mellitus: a population-based matched case-control study","volume":"173","author":"Singh S","year":"2013","unstructured":"Singh S, Chang HY, Richards TM, Weiner JP, Clark JM, Segal JB. Glucagonlike peptide 1-based therapies and risk of hospitalization for acute pancreatitis in type 2 diabetes mellitus: a population-based matched case-control study. JAMA Intern Med. 2013, 173:534-9. 10.1001\/jamainternmed.2013.2720","journal-title":"JAMA Intern Med"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1002\/edm2.70113","article-title":"Evaluating the rates of pancreatitis and pancreatic cancer among GLP-1 receptor agonists: a systematic review and meta-analysis of randomised controlled trials","volume":"8","author":"Wen J","year":"2025","unstructured":"Wen J, Nadora D, Bernstein E, et al.. Evaluating the rates of pancreatitis and pancreatic cancer among GLP-1 receptor agonists: a systematic review and meta-analysis of randomised controlled trials. Endocrinol Diabetes Metab. 2025, 8:e70113. 10.1002\/edm2.70113","journal-title":"Endocrinol Diabetes Metab"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14030944","article-title":"Pancreatitis risk associated with GLP-1 receptor agonists, considered as a single class, in a comorbidity-free subgroup of type 2 diabetes patients in the United States: a propensity score-matched analysis","volume":"14","author":"Ayoub M","year":"2025","unstructured":"Ayoub M, Chela H, Amin N, Hunter R, Anwar J, Tahan V, Daglilar E. Pancreatitis risk associated with GLP-1 receptor agonists, considered as a single class, in a comorbidity-free subgroup of type 2 diabetes patients in the United States: a propensity score-matched analysis. J Clin Med. 2025, 14:944. 10.3390\/jcm14030944","journal-title":"J Clin Med"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2024.111806","article-title":"The incidence of acute pancreatitis with GLP-1 receptor agonist therapy in individuals with a known history of pancreatitis","volume":"215","author":"Lomeli LD","year":"2024","unstructured":"Lomeli LD, Kodali AM, Tsushima Y, Mehta AE, Pantalone KM. The incidence of acute pancreatitis with GLP-1 receptor agonist therapy in individuals with a known history of pancreatitis. Diabetes Res Clin Pract. 2024, 215:111806. 10.1016\/j.diabres.2024.111806","journal-title":"Diabetes Res Clin Pract"},{"key":"ref48","unstructured":"VICTOZA\u00ae (liraglutide) injection, for subcutaneous use. (2017). Accessed. December 6, 2025: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2017\/022341s027lbl.pdf."},{"key":"ref49","unstructured":"ZEPBOUND\u00ae (tirzepatide) Injection, for subcutaneous use. (2024). Accessed. December 6, 2025: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2024\/217806s003lbl.pdf."},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1007\/s11695-014-1337-4","article-title":"Acute pancreatitis in patients after bariatric surgery: incidence, outcomes, and risk factors","volume":"24","author":"Kumaravel A","year":"2014","unstructured":"Kumaravel A, Zelisko A, Schauer P, Lopez R, Kroh M, Stevens T. Acute pancreatitis in patients after bariatric surgery: incidence, outcomes, and risk factors. Obes Surg. 2014, 24:2025-30. 10.1007\/s11695-014-1337-4","journal-title":"Obes Surg"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v5.i4.140","article-title":"Efficacy of intragastric balloon on weight reduction: Saudi perspective","volume":"5","author":"Almeghaiseeb ES","year":"2017","unstructured":"Almeghaiseeb ES, Ashraf MF, Alamro RA, Almasoud AO, Alrobayan AA. Efficacy of intragastric balloon on weight reduction: Saudi perspective. World J Clin Cases. 2017, 5:140-7. 10.12998\/wjcc.v5.i4.140","journal-title":"World J Clin Cases"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1097\/MOG.0000000000000386","article-title":"Obesity and pancreatitis","volume":"33","author":"Khatua B","year":"2017","unstructured":"Khatua B, El-Kurdi B, Singh VP. Obesity and pancreatitis. Curr Opin Gastroenterol. 2017, 33:374-82. 10.1097\/MOG.0000000000000386","journal-title":"Curr Opin Gastroenterol"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1016\/j.obmed.2025.100585","article-title":"Cytokines as key players in obesity low grade inflammation and related complications","volume":"54","author":"Ejim Uti D","year":"2025","unstructured":"Ejim Uti D, Atangwho IJ, Omang WA, et al.. Cytokines as key players in obesity low grade inflammation and related complications. Obes Med. 2025, 54:100585. 10.1016\/j.obmed.2025.100585","journal-title":"Obes Med"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3002573","article-title":"Lipotoxicity causes multisystem organ failure and exacerbates acute pancreatitis in obesity","volume":"3","author":"Navina S","year":"2011","unstructured":"Navina S, Acharya C, DeLany JP, et al.. Lipotoxicity causes multisystem organ failure and exacerbates acute pancreatitis in obesity. Sci Transl Med. 2011, 3:107ra110. 10.1126\/scitranslmed.3002573","journal-title":"Sci Transl Med"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-023-00932-2","article-title":"Emerging mechanisms of obesity-associated immune dysfunction","volume":"20","author":"Shaikh SR","year":"2024","unstructured":"Shaikh SR, Beck MA, Alwarawrah Y, MacIver NJ. Emerging mechanisms of obesity-associated immune dysfunction. Nat Rev Endocrinol. 2024, 20:136-48. 10.1038\/s41574-023-00932-2","journal-title":"Nat Rev Endocrinol"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathmechdis-051222-015350","article-title":"Immune dysregulation in obesity","volume":"20","author":"Jiang Z","year":"2025","unstructured":"Jiang Z, Tabuchi C, Gayer SG, Bapat SP. Immune dysregulation in obesity. Annu Rev Pathol. 2025, 20:483-509. 10.1146\/annurev-pathmechdis-051222-015350","journal-title":"Annu Rev Pathol"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-36266-7","article-title":"Obesity aggravates acute pancreatitis via damaging intestinal mucosal barrier and changing microbiota composition in rats","volume":"9","author":"Ye C","year":"2019","unstructured":"Ye C, Liu L, Ma X, et al.. Obesity aggravates acute pancreatitis via damaging intestinal mucosal barrier and changing microbiota composition in rats. Sci Rep. 2019, 9:69. 10.1038\/s41598-018-36266-7","journal-title":"Sci Rep"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.5009\/gnl.2011.5.3.335","article-title":"Influence of obesity on the severity and clinical outcome of acute pancreatitis","volume":"5","author":"Shin KY","year":"2011","unstructured":"Shin KY, Lee WS, Chung DW, et al.. Influence of obesity on the severity and clinical outcome of acute pancreatitis. Gut Liver. 2011, 5:335-9. 10.5009\/gnl.2011.5.3.335","journal-title":"Gut Liver"},{"key":"ref59","article-title":"Relationship between obesity and pancreatitis","author":"Navina S","year":"2015","unstructured":"Navina S, Singh VP. Relationship between obesity and pancreatitis. Pancreapedia: Exocrine Pancreas Knowledge Base. American Pancreatic Association, Prairie Village, KS; 2015."},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.93044","article-title":"The obesity-pancreatitis conundrum in the Asian population: a systematic review and meta-analysis of methodological insights with clinical outcomes","volume":"17","author":"Vadukoot Lazar M","year":"2025","unstructured":"Vadukoot Lazar M, Shejal A, Mathew PJ, Zacharia GS, Patel H, Ukken J, Thomas J. The obesity-pancreatitis conundrum in the Asian population: a systematic review and meta-analysis of methodological insights with clinical outcomes. Cureus. 2025, 17:e93044. 10.7759\/cureus.93044","journal-title":"Cureus"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v25.i6.729","article-title":"Body-mass index correlates with severity and mortality in acute pancreatitis: a meta-analysis","volume":"25","author":"Dobszai D","year":"2019","unstructured":"Dobszai D, M\u00e1trai P, Gy\u00f6ngyi Z, et al.. Body-mass index correlates with severity and mortality in acute pancreatitis: a meta-analysis. World J Gastroenterol. 2019, 25:729-43. 10.3748\/wjg.v25.i6.729","journal-title":"World J Gastroenterol"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.1800800426","article-title":"Obesity: an important prognostic factor in acute pancreatitis","volume":"80","author":"Funnell IC","year":"1993","unstructured":"Funnell IC, Bornman PC, Weakley SP, Terblanche J, Marks IN. Obesity: an important prognostic factor in acute pancreatitis. Br J Surg. 1993, 80:484-6. 10.1002\/bjs.1800800426","journal-title":"Br J Surg"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-019-1015-z","article-title":"Impact of visceral adiposity on severity of acute pancreatitis: a propensity score-matched analysis","volume":"19","author":"Xie J","year":"2019","unstructured":"Xie J, Xu L, Pan Y, Li P, Liu Y, Pan Y, Xu L. Impact of visceral adiposity on severity of acute pancreatitis: a propensity score-matched analysis. BMC Gastroenterol. 2019, 19:87. 10.1186\/s12876-019-1015-z","journal-title":"BMC Gastroenterol"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1016\/j.pccm.2024.05.004","article-title":"Association of ratios of visceral fat area\/subcutaneous fat area and muscle area\/standard body weight at T12 CT level with the prognosis of acute respiratory distress syndrome","volume":"2","author":"Shen H","year":"2024","unstructured":"Shen H, He Y, Lu F, Lu X, Yang B, Liu Y, Guo Q. Association of ratios of visceral fat area\/subcutaneous fat area and muscle area\/standard body weight at T12 CT level with the prognosis of acute respiratory distress syndrome. Chin Med J Pulm Crit Care Med. 2024, 2:106-18. 10.1016\/j.pccm.2024.05.004","journal-title":"Chin Med J Pulm Crit Care Med"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.3390\/nu17142310","article-title":"Obesity and pancreatic diseases: from inflammation to oncogenesis and the impact of weight loss interventions","volume":"17","author":"Souto M","year":"2025","unstructured":"Souto M, C\u00fardia Gon\u00e7alves T, Cotter J. Obesity and pancreatic diseases: from inflammation to oncogenesis and the impact of weight loss interventions. Nutrients. 2025, 17:2310. 10.3390\/nu17142310","journal-title":"Nutrients"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1097\/MPA.0000000000001252","article-title":"Association of pancreatic steatosis with chronic pancreatitis, obesity, and type 2 diabetes mellitus","volume":"48","author":"Tirkes T","year":"2019","unstructured":"Tirkes T, Jeon CY, Li L, et al.. Association of pancreatic steatosis with chronic pancreatitis, obesity, and type 2 diabetes mellitus. Pancreas. 2019, 48:420-6. 10.1097\/MPA.0000000000001252","journal-title":"Pancreas"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1186\/s12199-019-0763-2","article-title":"Impact of fatty pancreas and lifestyle on the development of subclinical chronic pancreatitis in healthy people undergoing a medical checkup","volume":"24","author":"Fujii M","year":"2019","unstructured":"Fujii M, Ohno Y, Yamada M, Kamada Y, Miyoshi E. Impact of fatty pancreas and lifestyle on the development of subclinical chronic pancreatitis in healthy people undergoing a medical checkup. Environ Health Prev Med. 2019, 24:10. 10.1186\/s12199-019-0763-2","journal-title":"Environ Health Prev Med"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000003048","article-title":"The causal effect of intrapancreatic fat deposition on acute and chronic pancreatitis: a Mendelian randomization study","volume":"119","author":"Yamazaki H","year":"2024","unstructured":"Yamazaki H, Heni M, Wagner R, et al.. The causal effect of intrapancreatic fat deposition on acute and chronic pancreatitis: a Mendelian randomization study. Am J Gastroenterol. 2024, 119:2540-4. 10.14309\/ajg.0000000000003048","journal-title":"Am J Gastroenterol"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1159\/000225921","article-title":"Is obesity an additional risk factor for alcoholic chronic pancreatitis?","volume":"10","author":"Ammann RW","year":"2010","unstructured":"Ammann RW, Raimondi S, Maisonneuve P, Mullhaupt B. Is obesity an additional risk factor for alcoholic chronic pancreatitis?. Pancreatology. 2010, 10:47-53. 10.1159\/000225921","journal-title":"Pancreatology"},{"key":"ref70","article-title":"Prognosis of acute and chronic pancreatitis - a 30-year follow-up of a Danish cohort","volume":"57","author":"N\u00f8jgaard C","year":"2010","unstructured":"N\u00f8jgaard C. Prognosis of acute and chronic pancreatitis - a 30-year follow-up of a Danish cohort. Dan Med Bull. 2010, 57:B4228.","journal-title":"Dan Med Bull"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2023.12.019","article-title":"ESPEN practical guideline on clinical nutrition in acute and chronic pancreatitis","volume":"43","author":"Arvanitakis M","year":"2024","unstructured":"Arvanitakis M, Ockenga J, Bezmarevic M, et al.. ESPEN practical guideline on clinical nutrition in acute and chronic pancreatitis. Clin Nutr. 2024, 43:395-412. 10.1016\/j.clnu.2023.12.019","journal-title":"Clin Nutr"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1177\/0884533614528361","article-title":"The prevalence of malnutrition and fat-soluble vitamin deficiencies in chronic pancreatitis","volume":"29","author":"Duggan SN","year":"2014","unstructured":"Duggan SN, Smyth ND, O'Sullivan M, Feehan S, Ridgway PF, Conlon KC. The prevalence of malnutrition and fat-soluble vitamin deficiencies in chronic pancreatitis. Nutr Clin Pract. 2014, 29:348-54. 10.1177\/0884533614528361","journal-title":"Nutr Clin Pract"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-020-06275-6","article-title":"High body mass index and central adiposity is associated with increased risk of acute pancreatitis: a meta-analysis","volume":"66","author":"Aune D","year":"2021","unstructured":"Aune D, Mahamat-Saleh Y, Norat T, Riboli E. High body mass index and central adiposity is associated with increased risk of acute pancreatitis: a meta-analysis. Dig Dis Sci. 2021, 66:1249-67. 10.1007\/s10620-020-06275-6","journal-title":"Dig Dis Sci"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1016\/j.pan.2022.08.003","article-title":"The deleterious effects of smoking on the development and progression of chronic pancreatitis","volume":"22","author":"Han SY","year":"2022","unstructured":"Han SY, Conwell DL, Diaz PT, Ferketich A, Jeon CY, Yadav D, Hart PA. The deleterious effects of smoking on the development and progression of chronic pancreatitis. Pancreatology. 2022, 22:683-7. 10.1016\/j.pan.2022.08.003","journal-title":"Pancreatology"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1177\/17562848251365030","article-title":"Multiple substance use and the risk of pancreatitis: a systematic review","volume":"18","author":"Adeniran EA","year":"2025","unstructured":"Adeniran EA, Jiang Y, Yadav D, et al.. Multiple substance use and the risk of pancreatitis: a systematic review. Therap Adv Gastroenterol. 2025, 18:10.1177\/17562848251365030","journal-title":"Therap Adv Gastroenterol"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1007\/s13679-014-0129-4","article-title":"Alcohol consumption and obesity: an update","volume":"4","author":"Traversy G","year":"2015","unstructured":"Traversy G, Chaput JP. Alcohol consumption and obesity: an update. Curr Obes Rep. 2015, 4:122-30. 10.1007\/s13679-014-0129-4","journal-title":"Curr Obes Rep"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/735465","article-title":"Unraveling the relationship between smoking and weight: the role of sedentary behavior","volume":"2012","author":"Kaufman A","year":"2012","unstructured":"Kaufman A, Augustson EM, Patrick H. Unraveling the relationship between smoking and weight: the role of sedentary behavior. J Obes. 2012, 2012:735465. 10.1155\/2012\/735465","journal-title":"J Obes"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung H","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021, 71:209-49. 10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v24.i43.4846","article-title":"Pancreatic cancer: a review of clinical diagnosis, epidemiology, treatment and outcomes","volume":"24","author":"McGuigan A","year":"2018","unstructured":"McGuigan A, Kelly P, Turkington RC, Jones C, Coleman HG, McCain RS. Pancreatic cancer: a review of clinical diagnosis, epidemiology, treatment and outcomes. World J Gastroenterol. 2018, 24:4846-61. 10.3748\/wjg.v24.i43.4846","journal-title":"World J Gastroenterol"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-14-0155","article-title":"Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States","volume":"74","author":"Rahib L","year":"2014","unstructured":"Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 2014, 74:2913-21. 10.1158\/0008-5472.CAN-14-0155","journal-title":"Cancer Res"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.25794","article-title":"A pooled analysis of 14 cohort studies of anthropometric factors and pancreatic cancer risk","volume":"129","author":"Genkinger JM","year":"2011","unstructured":"Genkinger JM, Spiegelman D, Anderson KE, et al.. A pooled analysis of 14 cohort studies of anthropometric factors and pancreatic cancer risk. Int J Cancer. 2011, 129:1708-17. 10.1002\/ijc.25794","journal-title":"Int J Cancer"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdr398","article-title":"Body mass index, abdominal fatness and pancreatic cancer risk: a systematic review and non-linear dose-response meta-analysis of prospective studies","volume":"23","author":"Aune D","year":"2012","unstructured":"Aune D, Greenwood DC, Chan DS, et al.. Body mass index, abdominal fatness and pancreatic cancer risk: a systematic review and non-linear dose-response meta-analysis of prospective studies. Ann Oncol. 2012, 23:843-52. 10.1093\/annonc\/mdr398","journal-title":"Ann Oncol"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10102660","article-title":"Inflammation related to obesity in the etiopathogenesis of gastroenteropancreatic neuroendocrine neoplasms","volume":"10","author":"Budek M","year":"2022","unstructured":"Budek M, Nuszkiewicz J, Pi\u00f3rkowska A, Czuczejko J, Szewczyk-Golec K. Inflammation related to obesity in the etiopathogenesis of gastroenteropancreatic neuroendocrine neoplasms. Biomedicines. 2022, 10:2660. 10.3390\/biomedicines10102660","journal-title":"Biomedicines"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.14309\/ctg.0000000000000832","article-title":"Pancreatic steatosis as a risk factor for pancreatic ductal adenocarcinoma: pathogenesis and clinical implications","volume":"16","author":"Papalamprakopoulou Z","year":"2025","unstructured":"Papalamprakopoulou Z, Dey P, Frascati R, Fountzilas C. Pancreatic steatosis as a risk factor for pancreatic ductal adenocarcinoma: pathogenesis and clinical implications. Clin Transl Gastroenterol. 2025, 16:e00832. 10.14309\/ctg.0000000000000832","journal-title":"Clin Transl Gastroenterol"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.7150\/jca.16884","article-title":"Obesity and cancer: the role of adipose tissue and adipo-cytokines-induced chronic inflammation","volume":"7","author":"Divella R","year":"2016","unstructured":"Divella R, De Luca R, Abbate I, Naglieri E, Daniele A. Obesity and cancer: the role of adipose tissue and adipo-cytokines-induced chronic inflammation. J Cancer. 2016, 7:2346-59. 10.7150\/jca.16884","journal-title":"J Cancer"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.28303","article-title":"Myeloid-derived suppressor cells: cancer, autoimmune diseases, and more","volume":"13","author":"Shibata M","year":"2022","unstructured":"Shibata M, Nanno K, Yoshimori D, et al.. Myeloid-derived suppressor cells: cancer, autoimmune diseases, and more. Oncotarget. 2022, 13:1273-85. 10.18632\/oncotarget.28303","journal-title":"Oncotarget"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.1097\/JP9.0000000000000135","article-title":"Cellular crosstalk of regulatory T cells in pancreatic ductal adenocarcinoma","volume":"7","author":"Shi X","year":"2024","unstructured":"Shi X, Liu H, Liang Z. Cellular crosstalk of regulatory T cells in pancreatic ductal adenocarcinoma. J Pancreatol. 2024, 7:131-40. 10.1097\/JP9.0000000000000135","journal-title":"J Pancreatol"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1093257","article-title":"Obesity and endocrine-related cancer: the important role of IGF-1","volume":"14","author":"Zhong W","year":"2023","unstructured":"Zhong W, Wang X, Wang Y, Sun G, Zhang J, Li Z. Obesity and endocrine-related cancer: the important role of IGF-1. Front Endocrinol (Lausanne). 2023, 14:1093257. 10.3389\/fendo.2023.1093257","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2023.10.003","article-title":"Hyperinsulinemia acts via acinar insulin receptors to initiate pancreatic cancer by increasing digestive enzyme production and inflammation","volume":"35","author":"Zhang AM","year":"2023","unstructured":"Zhang AM, Xia YH, Lin JS, et al.. Hyperinsulinemia acts via acinar insulin receptors to initiate pancreatic cancer by increasing digestive enzyme production and inflammation. Cell Metab. 2023, 35:2119-35.e5. 10.1016\/j.cmet.2023.10.003","journal-title":"Cell Metab"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.926230","article-title":"The role of adipokines in pancreatic cancer","volume":"12","author":"Wang Q","year":"2022","unstructured":"Wang Q, Wang H, Ding Y, Wan M, Xu M. The role of adipokines in pancreatic cancer. Front Oncol. 2022, 12:926230. 10.3389\/fonc.2022.926230","journal-title":"Front Oncol"},{"key":"ref91","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.3844","article-title":"Metabolic-bariatric surgery reduces pancreatic cancer risk: a meta-analysis of over 3.7 million adults, independent of type 2 diabetes status","volume":"40","author":"Angelidi AM","year":"2024","unstructured":"Angelidi AM, Martinou EG, Karamanis DG. Metabolic-bariatric surgery reduces pancreatic cancer risk: a meta-analysis of over 3.7 million adults, independent of type 2 diabetes status. Diabetes Metab Res Rev. 2024, 40:e3844. 10.1002\/dmrr.3844","journal-title":"Diabetes Metab Res Rev"},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djae260","article-title":"Glucagon-like peptide-1 receptor agonists and pancreatic cancer risk: target trial emulation using real-world data","volume":"117","author":"Wang L","year":"2025","unstructured":"Wang L, Wang Q, Li L, Kaelber DC, Xu R. Glucagon-like peptide-1 receptor agonists and pancreatic cancer risk: target trial emulation using real-world data. J Natl Cancer Inst. 2025, 117:476-85. 10.1093\/jnci\/djae260","journal-title":"J Natl Cancer Inst"},{"key":"ref93","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2021.09.021","article-title":"Help or hindrance: the obesity paradox in cancer treatment response","volume":"522","author":"O'Connell F","year":"2021","unstructured":"O'Connell F, O'Sullivan J. Help or hindrance: the obesity paradox in cancer treatment response. Cancer Lett. 2021, 522:269-80. 10.1016\/j.canlet.2021.09.021","journal-title":"Cancer Lett"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/444532-the-fat-pancreas-axis-a-narrative-review-unraveling-the-role-of-obesity-in-pancreatic-diseases","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T22:20:11Z","timestamp":1765664411000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/444532-the-fat-pancreas-axis-a-narrative-review-unraveling-the-role-of-obesity-in-pancreatic-diseases"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,13]]},"references-count":93,"URL":"https:\/\/doi.org\/10.7759\/cureus.99148","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,13]]}}}